tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geoffrey Porges, 197 are a BUY (67.24%), 95 are a HOLD (32.42%), 1 are a SELL (0.34%).
Analyst Geoffrey Porges, currently employed at LEERINK, carries an average stock price target met ratio of 61.57% that have a potential upside of 29.07% achieved within 378 days. Previously, Geoffrey Porges worked at BERNSTEIN.
Geoffrey Porges’s has documented 600 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive sectors.
Most recent stock forecast was given on RCUS, Arcus Biosciences at 01-Mar-2026.
Analyst best performing recommendations are on DOVA (DOVA PHARMACEUTICALS).
The best stock recommendation documented was for TBPH (THERAVANCE BIOPHARMA) at 10/31/2016. The price target of $33 was fulfilled within 11 days with a profit of $7.87 (31.32%) receiving and performance score of 28.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Feb-2026
$325
$40.2 (14.12%)
$300
Buy Since 04-Feb-2020
$288
$3.2 (1.12%)
$288
13 days ago
(09-Oct-2026)
45/45 (100%)
$11.53 (4.17%)
407
Hold Since 06-Jan-2026
$275
$-9.8 (-3.44%)
$260
13 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Oct-2020
$300
$15.2 (5.34%)
$280
14 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
Buy Since 15-Nov-2023
$290
$5.2 (1.83%)
$285
14 days ago
(08-Oct-2026)
31/32 (96.88%)
$17.58 (6.45%)
251
What Year was the first public recommendation made by Geoffrey Porges?
